do medicare advantage plans cover glp 1 drugs to GLP-1 weight loss for $50/month What to Know About the

The covariates were adjusted in the PSM model for a priori-identified potential confounders, such as age, sex, race/ethnicity, nicotine dependence, BMI, type 2 diabetes, hypertension, hyperlipidaemia, hypercholesterolaemia, chronic respiratory disease, chronic renal diseases, BP, chronic kidney disease, peripheral vascular diseases, diabetes-related microvascular complications, glomerular diseases, cirrhosis of the liver, osteoporosis, sleep apnoea, abnormal laboratory findings (HbA 1c , serum cholesterol, LDL-cholesterol, HDL-cholesterol and triacylglycerol [TG]) and intake of cardiovascular medications (Table 1)

doi: 10.1093/jjco/hyy047 [DOI] [PubMed] [Google Scholar] 13

Comparison with previous studies The results of this study indicate that the combined use of GLP-1 receptor agonists and SGLT-2 inhibitors is associated with a lower risk of major adverse cardiovascular events, compared with the use of either drug class alone

The choice is guided by factors like patient preferences, adherence potential, side effect tolerability, comorbidities, administration logistics, and cost-access considerations, emphasizing shared decision-making for optimal outcomes. Learn more about taking GLP-1s when you have a digestive health condition

Improvements in glycemic parameters and quality of life measures were also observed